Clinical Trials Directory

Trials / Conditions / Acute Lymphoblastic Leukemia With Failed Remission

Acute Lymphoblastic Leukemia With Failed Remission

10 registered clinical trials studyying Acute Lymphoblastic Leukemia With Failed Remission — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingMB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
NCT07371403
King Hussein Cancer CenterN/A
Not Yet RecruitingSafety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL a
NCT05779930
Nationwide Children's HospitalEARLY_Phase 1
RecruitingCD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
NCT06445803
Rong TaoPhase 1
RecruitingBortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
NCT06034561
Instituto do Cancer do Estado de São PauloPhase 2
RecruitingDetermining the Mechanisms of Loss of CAR T Cell Persistence
NCT05809284
University College, London—
RecruitingVenetoclax Basket Trial for High Risk Hematologic Malignancies
NCT05292664
Andrew E. Place, MDPhase 1
TerminatedCAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL
NCT04049383
Medical College of WisconsinPhase 1
CompletedEfficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)
NCT03751072
Group for Research in Adult Acute Lymphoblastic Leukemia—
TerminatedTreatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT03515200
St. Jude Children's Research HospitalPhase 1
Active Not RecruitingCAR-T Cell Therapy Targeting to CD19 for R/R ALL
NCT03919240
The First Affiliated Hospital of Soochow UniversityPhase 1 / Phase 2